Meloxinew® 3% Injectable is a non-steroidal anti-inflammatory drug , at a concentration of 3%, with preferential activity in inhibiting cyclooxygenase 2 (COX-2). The main mechanism of action of Meloxinew® 3% Injectable is the preferential inhibition of COX-2 and, consequently, the ability to block the biosynthesis of prostaglandins, mediators of the inflammatory process . The preferential action on COX-2 minimizes side effects on the gastric mucosa of equines, which provides safe use, combined with the effectiveness of its anti-inflammatory action .

INDICATION

Meloxinew® 3% Injectable is indicated for the treatment of inflammation and pain (acute or chronic) in cases involving soft tissue and musculoskeletal conditions. It is also indicated for controlling pain and inflammation in the post-surgical period.

HOW TO USE

To be used in equines, intravenously or intramuscularly.

Administer at a dose of 0.6 mg/kg of body weight, equivalent to 2.0 mL of the product for every 100 kg, every 24 hours for 5 to 7 consecutive days. Dosages may be changed according to your veterinarian's instructions.

COMPOSITION

EACH 100 g CONTAINS

PRESENTATION

Bottle containing 50mL.

* Product considered DOPING according to the FEI (International Equestrian Federation) list. However, always consult the specific regulations of the event.